Literature DB >> 8941573

De novo expression of transforming growth factor-alpha in parathyroid gland tissue of patients with primary or secondary uraemic hyperparathyroidism.

J Gogusev1, P Duchambon, C Stoermann-Chopard, M Giovannini, E Sarfati, T B Drüeke.   

Abstract

BACKGROUND: The factors involved in abnormal parathyroid cell secretory function and growth in patients with primary and secondary hyperparathyroidism are still incompletely understood. PATIENTS AND METHODS: We studied the expression of transforming growth factor-alpha (TGF-alpha), epidermal growth factor (EGF) and EGF receptor (EGF-R) at the gene message and the protein level in parathyroid tissue obtained from six patients with primary hyperparathyroidism, 15 patients with secondary uraemic hyperparathyroidism and five subjects with normal parathyroid tissue, using in situ hybridization and/or immunostaining technique.
RESULTS: We found a consistent expression of TGF-alpha mRNA and protein in parathyroid endocrine cells of all six cases of primary parathyroid adenoma and in nearly all cases of secondary hyperplasia, in contrast to the absence of expression in normal parathyroid tissue. A marked expression of EGF-R mRNA and protein was also found in four of five tissue samples of primary parathyroid adenoma, in 13 of 15 tissue samples of secondary parathyroid hyperplasia and in most samples of normal parathyroid gland tissue. EGF mRNA and protein expression was undetectable in the majority of parathyroid tissue samples examined.
CONCLUSION: Since TGF-alpha is known to bind to the EGF-R, the finding of an increased expression of TGF-alpha at the gene message and the protein level, together with a strong expression of EGF-R, in hyperplastic and adenomatous parathyroid glands suggests that this growth factor interacts with its receptor to promote parathyroid cell proliferation, perhaps by an autocrine mechanism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8941573     DOI: 10.1093/oxfordjournals.ndt.a027131

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  12 in total

1.  Cycling with the parathyroid.

Authors:  J Silver
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

2.  The induction of C/EBPβ contributes to vitamin D inhibition of ADAM17 expression and parathyroid hyperplasia in kidney disease.

Authors:  Maria Vittoria Arcidiacono; Jing Yang; Elvira Fernandez; Adriana Dusso
Journal:  Nephrol Dial Transplant       Date:  2014-10-07       Impact factor: 5.992

3.  Parathyroid-specific epidermal growth factor-receptor inactivation prevents uremia-induced parathyroid hyperplasia in mice.

Authors:  Maria Vittoria Arcidiacono; Jing Yang; Elvira Fernandez; Adriana Dusso
Journal:  Nephrol Dial Transplant       Date:  2014-10-16       Impact factor: 5.992

4.  Phosphorylation of Ribosomal Protein S6 Mediates Mammalian Target of Rapamycin Complex 1-Induced Parathyroid Cell Proliferation in Secondary Hyperparathyroidism.

Authors:  Oded Volovelsky; Gili Cohen; Ariel Kenig; Gilad Wasserman; Avigail Dreazen; Oded Meyuhas; Justin Silver; Tally Naveh-Many
Journal:  J Am Soc Nephrol       Date:  2015-08-17       Impact factor: 10.121

5.  Activator protein 2alpha mediates parathyroid TGF-alpha self-induction in secondary hyperparathyroidism.

Authors:  Maria Vittoria Arcidiacono; Mario Cozzolino; Noah Spiegel; Masanori Tokumoto; Jing Yang; Yan Lu; Tetsuhiko Sato; Carlo Lomonte; Carlo Basile; Eduardo Slatopolsky; Adriana S Dusso
Journal:  J Am Soc Nephrol       Date:  2008-06-25       Impact factor: 10.121

6.  EGFR activation increases parathyroid hyperplasia and calcitriol resistance in kidney disease.

Authors:  Maria Vittoria Arcidiacono; Tetsuhiko Sato; Daniel Alvarez-Hernandez; Jing Yang; Masanori Tokumoto; Ignacio Gonzalez-Suarez; Yan Lu; Yoshihiro Tominaga; Jorge Cannata-Andia; Eduardo Slatopolsky; Adriana S Dusso
Journal:  J Am Soc Nephrol       Date:  2008-01-23       Impact factor: 10.121

Review 7.  Phosphate balance in ESRD: diet, dialysis and binders against the low evident masked pool.

Authors:  A Galassi; A Cupisti; A Santoro; M Cozzolino
Journal:  J Nephrol       Date:  2014-09-23       Impact factor: 3.902

Review 8.  Pathogenesis of parathyroid dysfunction in end-stage kidney disease.

Authors:  Ronen Levi; Justin Silver
Journal:  Pediatr Nephrol       Date:  2004-11-10       Impact factor: 3.714

9.  Expression of p53, Ki67, epidermal growth factor receptor, transforming growth-factorα, and p21 in primary and secondary hyperparathyroidism.

Authors:  Saime Paydas; Arbil Acikalim; Bulent Kaya; Bermal Hasbay Bicer; Mehmet Ulker; Orhan Demircan; Aysun Uguz; Mustafa Balal; Gurhan Sakman; Yasar Sertdemir; Refika Karaer; Eda Altun
Journal:  Indian J Endocrinol Metab       Date:  2014-11

10.  Inhibition by transforming growth factor (34-43)-alpha, a TGF-alpha antagonist, of gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats.

Authors:  M Tatsuta; H Iishi; M Baba; R Hirasawa; K Iseki; H Yano; N Sakai; H Uehara; A Nakaizumi
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.